It has been known for sometime that adultlneonatal rat and fetal rabbit brain contain an insulin-like substance whose precise identity, however, has remained in doubt. In an effort to clarify this issue, fetal rabbit brains (22-25-27d gestation; term-3ld) were collected and either sliced for peroxidase-antiperoxidase (PAP) staining or extracted with an acid ethanol for SDS-PA gel and ELISA determinations. The monoclonal antibody used for PAP and ELISA analyses recognized insulin but not IGF-I.
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USEFULNESS OF THYROTROPIN

8 ,
Allen W. Root. University of South Florida College of Medicine, All Children's Hospital, Dept. of Pediatrics, St. Petersburg. EL 33731. Seven infants with congenital hypothyroidism (TSH 12-603 uIU/ mL) and their mothers were screened for TBII. Two siblings with transient congenital hypothyroidism (T4-6.3, 6.9 ug/dL; TSH-397, 211 uIU/mL) were found to have significant elevation of serum TBII index (90,10O;n1<10) at birth equal to that measured in the mother's serum. Technetium scan in the first-born child at 14 days revealed no thyroid gland. Repeat scan at 2 years after withdrawing thyroxine therapy was normal. In light of presumed maternal antibody-mediated hypothyroidism in the first child, hypothyroidism was predicted correctly in the second child and thyroxine therapy initiated on day 1 of life. In contrast, mild elevation of TBII index (12,131 was found in serum of two additional infants but not in maternal serum (TBII(1,7) suggesting that elevated TSH concentrations might be crossreacting in the TBII assay in these two infants. Twelve additional children (11-primary hypothyroidism, 1-thyroid hormone resistance) with elevated TSH concentrations (12-1355 uIUImL) were tested for TBII. Four were positive (TBII 13-21). TBII correlated significantly with TSH concentrations (r=0.73, pL01). TSH concentrations<lOO uIU/mL were not associated with a positive TBII. TBII may prove useful in screening infants with congenital hypothyroidism caused by maternal TSH-blocking antibodies. However, since high concentrations of TSH may crossreact in this assay maternal serum should be simultaneously assessed. additional DOC infusion caused t r a n s i e n t hypertension and expected renin suppression. W e postulate t h a t down-regulation of MRBS is an adaptive response t o high DOC, i n h i b i t i n g mineralocorticoid effects.
Normal basal aldo levels indicate i n t a c t glomerulosa ll&hydroxylation, suggesting a defect in t i s s u e -s p e c i f i c expression of t h e enzyme, rather than a structural qene defect. The presence of high concentrations of IGF-I1 in cerebrospinal fluid and brain, as well as the prominence of receptors in cortical tissues, make the CNS an attractive s i t e for the study of IGF-I1 binding and action. 8-104 i s a transformed r a t neuroblastoma cell line whose neuronal qualities include neurotransmitter synthesis and the ability to project axodendritic processes. W e observed steady-state binding of 125-I-IGF-I1 to 8-104 membranes between 1.5 and 4 hrs a t optimal conditions of 25*C, pH 7-8. Specific binding averaged 12.2+4.0% per 100 uglml membrane protein, compared with 125-I-IGF-I binding of 10.1+2.9%. 125-I-IGF-I1 binding was minimally inhibited (*20%) by insulin concentrations as high as 100 uglml. In the presence of unlabeled IGF-I1 (0.5-5ng/ml), 125-I-IGF-I1 binding was increased by as much as 50% over baseline; a t higher concentrations, 125-I-IGF-I1 binding was inhibited, with 50% displacement a t 50 nglml. We observed a similar increase in 125-I-IGF-I1 binding in the presence of unlabeled IGF-I a t concentrations ranging from 1-400 ng/ml . When 125-I-IGF-I1 was cross-linked to membranes, solubilized, and immunoprecipitated with a specific antibody for the r a t IGF-I I receptor, a classical type I I receptor (Mr440K) was visualized upon electrophoresis. These results demonstrate the presence in 8-104 cells of a specific high affinity type I1 recept o r , as well as a membrane-bound binding protein, whose existence in conditioned medium was confirmed by activated charcoal assay.
8-104 should serve as an appropriate and intriguing fi vi tro model for future study of IGF receptors and action in the CNS-
